Home/Recalls/FDA-D-0496-2026
FDA DrugsClass II

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical In...

Published: April 29, 2026Recall ID: D-0496-2026Category: drugsCountry: US

Reason for Recall / Hazard

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Product Description & Identification

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.

Additional Source Details

FieldValue
CityAllentown
StatePA
Openfda › UniiIY9XDZ35W2
Openfda › RouteINTRAVENOUS
Openfda › Rxcui237656
Openfda › Spl id200c4b9e-283a-4dea-b33a-9bb4936b2b99
Openfda › Brand nameDEXTROSE
Openfda › Spl set id8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0
Openfda › Package ndc0264-7387-50
Openfda › Product ndc0264-7387
Openfda › Generic nameDEXTROSE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameDEXTROSE
Openfda › Manufacturer nameB. Braun Medical Inc.
Openfda › Application numberNDA019626
Openfda › Is original packagertrue
Event id98693
Address 1861 Marcon Blvd
Address 2N/A
Code infoLot # J5H166, J5H167, Exp Date: 30NOV2026.
Postal code18109-9577
Report date20260429
Product typeDrugs
Product quantity17,124 bags
Reason for recallLack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260402
Initial firm notificationLetter
Center classification date20260428

Overview

  • Recalling FirmB BRAUN MEDICAL INC
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS Nationwide.
Official Agency Alert